Smartphone Application for University Students With Binge Drinking Behavior
SmartBinge
1 other identifier
interventional
628
1 country
1
Brief Summary
Alcohol use is a causal factor in more than 200 diseases and injury conditions (see ICD-10) and in France, alcohol is the first cause of hospitalization. Binge drinking (BD) has emerged as a major public health issue among student populations and is associated with negative consequences and social, cognitive and brain alterations. More than half of French university students have reported BD in the past month and are at increased risk of several alcohol-related consequences such as memory and sleep impairments, and reduced quality of life. BD is also a major risk factor in the development of alcohol addiction, with individual and environmental factors playing a role that is still poorly understood. Moreover, most students and young adults are reluctant to seek interventions when it is provided by health care professionals (only 4-5%) and have poor insight with regard to their alcohol use patterns / habits. Thus, there is an urgent need for developing effective prevention and intervention programs to reduce alcohol drinking in students. Recent studies have demonstrated that new types of technology-delivered interventions are promising tools for addressing unhealthy alcohol use. For example, an uncontrolled trial pilot study using a smartphone application-delivered intervention produced a reduction in both number of drinks per week and BD from baseline to 3-month follow-up. A recent review also showed significant outcomes of a mobile health intervention for self-control of unhealthy alcohol use. The investigators hypothesize that a timeline follow-back and personalized feedback based on the use of a mobile application can reduce excessive alcohol intake at 3-months. This study will provide scientific knowledge about BD in students, but also regarding a new type of intervention that could be effective for prevention in non-treatment seeking individuals and reducing the severity of health problems associated with excessive alcohol intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 10, 2023
CompletedFirst Posted
Study publicly available on registry
October 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedMay 25, 2025
May 1, 2025
2.5 years
October 10, 2023
May 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of the number of standard drinks per week
30 months
Secondary Outcomes (10)
Change of the PEth concentration
3 months
Change of the PEth concentration
6 months
Change of the PEth concentration
9 months
Change of the PEth concentration
12 months
Change of the PEth concentration
15 months
- +5 more secondary outcomes
Study Arms (2)
Binge Drinking
EXPERIMENTALBinge Drinking-control
ACTIVE COMPARATORInterventions
blood microsampling for the measure of Phosphatidylethanol
Eligibility Criteria
You may qualify if:
- Students between 18 and 25 years old
- AUQ score greater than or equal to 24, and AUDIT score greater than or equal to 3 for its first 3 items. Drinking details with the DDQ when necessary.
- BD behavior: at least one occasion with 6 or more drinks in the last 3 months.
- Consent to be included in the study
- Affiliated to social security
You may not qualify if:
- Not having a smartphone with an Apple or Android system.
- Previous use of the MyDéfi smartphone application
- Declaration of a psychiatric / neurologic condition
- Pregnant, parturient or breastfeeding woman
- Subject under guardianship, curators or restricted under public law
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire, Amienslead
- EPSM Marne, Reimscollaborator
- SCA-LAB UMR-CNRS 9193, Lillecollaborator
- Paul Valery University, Montpelliercollaborator
Study Sites (1)
CHU Amiens Picardie
Amiens, Picardie, 80054, France
Related Publications (1)
Andre C, Sauton P, Dreinaza M, Diouf M, Bodeau S, Martinetti M, Trouillet R, de Groote C, Nandrino JL, Alexandre A, Benzerouk F, Gierski F, Perney P, Grellet L, Andre J, Naassila M. Effect of the MyDefi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double-Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker-The SMARTBINGE Trial. Int J Methods Psychiatr Res. 2025 Jun;34(2):e70014. doi: 10.1002/mpr.70014.
PMID: 40165584DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2023
First Posted
October 16, 2023
Study Start
October 1, 2023
Primary Completion
April 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
May 25, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share